한빛사논문
Jong-Chan Park 1 2 3 †, Jong Won Han 4 †, Woochan Lee 4 5, Jieun Kim 4, Sang-Eun Lee 6 7 8 9, Dongjoon Lee 4, Hayoung Choi 4, Jihui Han 4, You Jung Kang 1 2, Yen N Diep 1 2 10, Hansang Cho 1 2 10, Rian Kang 2 3, Won Jong Yu 2 3, Jean Lee 11, Murim Choi 11, Sun-Wha Im 12, Jong-Il Kim 5 11 13 14, Inhee Mook-Jung 4 15 *
1Department of Biophysics, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
2Institute of Quantum Biophysics, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
3Department of Metabiohealth, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
4Department of Biochemistry and Biomedical Sciences, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea.
5Genome Medicine Institute, Medical Research Center, Seoul National University, Seoul, 03080, Republic of Korea.
6Department of Physiology and Biomedical Sciences, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea.
7BK21 FOUR Biomedical Science Program, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea.
8UK Dementia Research Institute, Institute of Neurology, University College London, Gower Street, London, WC1E 6BT, UK.
9Neuroscience Research Institute, Seoul National University Medical Research Center, Seoul, 03080, Republic of Korea.
10Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
11Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea.
12Department of Biochemistry and Molecular Biology, Kangwon National University School of Medicine, Gangwon, Seoul, 24341, Republic of Korea.
13Cancer Research Institute, Seoul National University, Seoul, 03080, Republic of Korea.
14Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
15Convergence Dementia Research Center, College of Medicine, Seoul National University, Seoul, 03080, Republic of Korea.
*Corresponding author: correspondence to Inhee Mook-Jung
†J.-C.P. and J.W.H. contributed equally to this work.
Abstract
Microglia play a crucial role in synaptic elimination by engulfing dystrophic neurons via triggering receptors expressed on myeloid cells 2 (TREM2). They are also involved in the clearance of beta-amyloid (Aβ) plaques in Alzheimer's disease (AD); nonetheless, the driving force behind TREM2-mediated phagocytosis of beta-amyloid (Aβ) plaques remains unknown. Here, using advanced 2D/3D/4D co-culture systems with loss-of-function mutations in TREM2 (a frameshift mutation engineered in exon 2) brain organoids/microglia/assembloids, it is identified that the clearance of Aβ via TREM2 is accelerated by externalized phosphatidylserine (ePtdSer) generated from dystrophic neurons surrounding the Aβ plaques. Moreover, it is investigated whether microglia from both sporadic (CRISPR-Cas9-based APOE4 lines) and familial (APPNL-G-F/MAPT double knock-in mice) AD models show reduced levels of TREM2 and lack of phagocytic activity toward ePtdSer-positive Aβ plaques. Herein new insight is provided into TREM2-dependent microglial phagocytosis of Aβ plaques in the context of the presence of ePtdSer during AD progression.
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기